Volume : 09, Issue : 03, March – 2022
Title:
15.ROLE OF A CLINICAL PHARMACIST IN THE MANAGEMENT OF HYPERTENSION AND DIABETES MELLITUS: THE TWIN DISEASE
Authors :
Swarna Priya B, K. Tharun*, Divyansh Dixit
Abstract :
Background: Hypertension and diabetes are paramount diseases in the lifestyle disease catalog. Even with specific treatments available, the prevalence of diabetes with hypertension has got special attention. Regarding the various complications of this twin disease, the required therapeutic outcome, along with non-compliance and improved quality of life, can be attained by clinical pharmacy services. The current study aimed to investigate the evidence to summarize the role of clinical pharmacists to flatten the curve.
Main body: The functional triage role of clinical pharmacists includes providing pharmaceutical care, enhancing medication management, and ADR monitoring. Pharmaceutical care services include analyzing drug-related problems regarding cost-effectiveness, better outcome, safety, and efficacy. Medication management includes strategies for the selection of drugs, applicable drugs, ADR monitoring, and assessing drug-drug interactions, drug-food interactions to accomplish safe, efficient, and cost-effective therapy. Also, an essential resource of patient counseling can gradually decrease the risk of medicine mismanagement, non-compliance, and non-adherence. The advantage is also added in the case of prescribing by implementing rational drug use and addressing ADR, interactions, and patient counseling information.
Conclusion: However, all available studies reported some positive impact resulting from clinical pharmacist involvement, and evaluating that outcome is improved. Targeting multiple risk factors is crucial in preventing and slowing the progression of these complications. Appropriate education and awareness among the patient and caregivers can result in stunning outcomes. In contrast, only clinical pharmacists from the health care team can keep the track in productive ways and bridge the gap between the patients and the health care team.
Keywords: Clinical pharmacist, Clinical pharmacy services, Diabetes Mellitus, Hypertension, Lifestyle disease, Outcomes, Twin disease.
Cite This Article:
Please cite this article in press K. Tharun et al, Role Of A Clinical Pharmacist In The Management Of Hypertension And Diabetes Mellitus: The Twin Disease., Indo Am. J. P. Sci, 2022; 09(3),.
Number of Downloads : 10
References:
1. Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Himmelfarb, C. D., Depalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., Maclaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., … Gentile, F. (2018). Clinical Practice Guideline 2017 ACC / AHA / AAPA / ABC / ACPM / AGS / APhA / ASH / ASPC / NMA / PCNA Guideline for the Prevention , Detection , Evaluation , and Management of High Blood Pressure in Adults A Report of the American College of Cardiology / American Heart Association Task Force on Clinical Practice Guidelines. https://doi.org/10.1161/HYP.0000000000000065.
2. NIDDK: diabetes overview; health information; Dec 2016.
3. Schramm, T. K., Gislason, G. H., Køber, L., Hansen, M. L., Folke, F., Buch, P., & Madsen, M. (2008). Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk A Population Study of 3 . 3 Million People. https://doi.org/10.1161/CIRCULATIONAHA.107.720847
4. Ferrannini, E, Cushman, WC. Diabetes and hypertension: the bad companions. Lancet. 380 (9841); 2012:601 10
5. Cheung, B. M. Y., & Li, C. (2012). Diabetes and Hypertension : Is There a Common Metabolic Pathway ? 160–166. https://doi.org/10.1007/s11883-012-0227-2
6. Arauz-Pacheco, C., Parrott, M. A., & Raskin, P. (2002). The treatment of hypertension in adult patients with diabetes. Diabetes Care, 25(1), 134–147. https://doi.org/10.2337/diacare.25.1.134
7. Konzem SL, Devore VS, Bauer DW. Controlling hypertension in patients with diabetes [published correction appears in Am Fam Physician. 2003 Mar 15;67(6):1195]. Am Fam Physician. 2002;66(7):1209-1214.
8. Between Advanced Retinopathy and. (2012). 35(April), 2317–2323. https://doi.org/10.2337/dc12-0628.
9. Mohan, V., Seedat, Y. K., & Pradeepa, R. (2013). The Rising Burden of Diabetes and Hypertension in Southeast Asian and African Regions : Need for Effective Strategies for Prevention and Control in Primary Health Care Settings. 2013.
10. Manuscript, A. (2013). NIH Public Access. 13(4), 244–251. https://doi.org/10.1111/j.1751-7176.2011.00434.x.
11. Simonson, D. C. (1988). Etiology and Prevalence of Hypertension in Diabetic Patients. 11(10), 821–827.
12. Ferrannini, E, Cushman, WC. Diabetes and hypertension: the bad companions. Lancet. 380 (9841); 2012:601 10
13. Diabetes, V. I. I., & In, C. (2006). CONTENTS DIAGNOSIS. 29.
14. Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., Lauer, M. S., Shaw, L. J., Smith, S. C., Taylor, A. J., Weintraub, W. S., Wenger, N. K., Smith, S. C., Past, I., Buller, C. E., Creager, M. A., & Ettinger, S. M. (2010). ACCF / AHA Practice Guideline Practice Guidelines 2010 ACCF / AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults : Executive Summary A Report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines CV Risk Guideline : Executive Summary. 2748–2764. https://doi.org/10.1161/CIR.0b013e3182051bab
15. Cryer MJ, Horani T, DiPette DJ. Diabetes and Hypertension: A Comparative Review of Current Guidelines. J Clin Hypertens (Greenwich). 2016 Feb;18(2):95-100. doi: 10.1111/jch.12638. Epub 2015 Aug 3. PMID: 26234374.
16. Ganachari M S, Mahendra Kumar B J, Shashikala C Wali and Fibin M; Assessment of Drug therapy interventions by clinical pharmacist in tertiary care hospital; Indian Journal of Pharmacy Practice; 2010;3(3):22-28.
17. Heisler, M., Hofer, T. P., Schmittdiel, J. A., Selby, J. V, Klamerus, M. L., Bosworth, H. B., Bermann, M., & Kerr, E. A. (2012). Improving Blood Pressure Control Through a Clinical Pharmacist Outreach Program in Patients With Diabetes Mellitus in 2 High-Performing Health Systems The Adherence and Intensification of Medications Cluster Randomized , Controlled Pragmatic Trial. 152. https://doi.org/10.1161/CIRCULATIONAHA.111.089169
18. Ramanath, K. V., & Venkappa, K. R. (2013). Study the impact of clinical pharmacist provided patient counseling on hypertension management in rural Indian population. 4(1). https://doi.org/10.4103/2045-080X.111579
19. Maja, L., Masia, T., Binyane, K., & Ramathebane, M. (2018). Original Article assessment of patient counselling in diabetic and hypertensive patients in terms of patient knowledge about their medication , disease state and lifestyle modifications by pharmacy personnel at ldf clinic in maseru. 10(3).
20. Setter SM, White JR, Campbell RK. Diabetes. In: Herfindal ET and Gourley DR, editors. Textbook of therapeutics drug and disease management. Lippincots Williams & Wilkins, Baltimore. 7th edition; 377- 406
21. Tina M. Nester, Pharm.D., LaDonna S. Hale, Pharm.D., Effectiveness of a pharmacist-acquired medication history in promoting patient safety, American Journal of Health-System Pharmacy, Volume 59, Issue 22, 15 November 2002, Pages 2221–2225.
22. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999;19(5):556-564.
23. Beers MH, Munekata M, Storrie M. The accuracy of medication histories in the hospital medical records of elderly persons. Journal of the American Geriatrics Society. 1990 Nov;38(11):1183-1187
24. Sihvo S, Klaukka T, Martikainen J, Hemminki E. Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population. Eur J Clin Pharmacol. 2000;56(6-7):495-499.
25. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes care 2004; 27 (Suppl 1): S15- S35.
26. Hohmann, C., Radziwill, R., Klotz, J. M., & Jacobs, A. H. (2010). Health-Related Quality of Life after Ischemic Stroke : The Impact of Pharmaceutical Interventions on Drug Therapy ( Pharmaceutical Care Concept ). 1–7.
27. Oki JC, Isley WL. Diabetes mellitus. In: Dipiro JT, Talbert RL, Yee GC et al, editors. Pharmacotherapy: a pathophysiological approach. Appleton & Lange, Connecticut, 5th edition; 1335
28. DIABETES CARE, VOLUME 26, SUPPLEMENT 1, JANUARY 2003 Treatment of hypertension in adults with diabetes S80-S82.
29. Factsheet, WHO, 29th April 2020); Salt Reduction and Healthy diet; https://www.who.int/news-room/fact-sheets/detail
30. Greer, R. C., Marklund, M., Anderson, C. A. M., Cobb, L. K., Dalcin, A. T., Henry, M., & Appel, L. J. (2020). Potassium-Enriched Salt Substitutes as a Means to Lower Blood Pressure: Benefits and Risks. Hypertension, 266-274.
31. Shareef JA, Fernandes JE, Samaga LA, Khader SA. A study on adverse drug reactions in hospitalized patients with diabetes mellitus in a multi-specialty teaching hospital. Asian J Pharm Clin Res 2016;9:114-7.
32. Singh P, Raj S, Chegini Z. Systematic Review on the Role of a Clinical Pharmacist In Patient Management According to the Pharmaceutical Care Concept. Int J Adv Res Pharm Edu 2019; 1(1): 15-21.